Meningococcal vaccine - Meningococcal Vaccine (Intramuscular Route, Subcutaneous Route) Description and Brand Names

Proof of vaccination with quadrivalent ACYW-135 is required for travellers going to Hajj and Umrah in Saudi Arabia.

This decision was reverted in favor of Bexsero vaccination in March 2014.

Cambridge, MA: Novartis; January 2015.

Hib-MenCY-TT is not indicated for prevention of disease caused by meningococcal serogroup B, the most common serogroup causing disease in infants, or serogroups W135 or A, which are represented in quadrivalent meningococcal vaccines.

Meningococcal vaccine

Hib-MenCY-TT provides the first therapeutic option for vaccination of infants as young as 6 weeks of age who are at increased risk for meningococcal disease.

The ACIP 2015 recommends serogroup B meningococcal vaccination for people aged 10 years and older at elevated risk for meningococcal disease.

Description: These researchers stated that future, large, longitudinal vaccination studies evaluating also clinical protection against IMD or carriage acquisition are needed to validate the currently proposed threshold in saliva.

Views: 8369 Date: 04.05.2022 Favorited: 148 favorites
Category: DEFAULT

User Comments 3

Post a comment

Persons with moderate or severe illness should be immunized as soon as they have recovered from the acute phase of the illness.
In countries with a low risk of disease, they recommend that high risk groups should be immunized.
Generally, only a single dose of meningococcal vaccine is indicated.

Hot Categories

Latest Comments

    Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with your preteen’s doctor about meningococcal vaccination to help protect your child’s health.
    By: f-r-m|||||||||
    Meningococcal (MenACWY) VIS. Many Vaccine Information Statements are available in Spanish and other languages. See
    By: chris-za|||||||||
    Meningococcal groups C and Y and Haemophilus b tetanus toxoid conjugate vaccine (Hib-MenCY-TT [MenHibrix, GlaxoSmithKline Biologicals]) is licensed for active immunization for prevention of invasive disease caused by Haemophilus influenzae type b (Hib) and meningococcal serogroups C and Y. Hib-MenCY-TT is not indicated for prevention of disease.
    By: bhushanchhaya|||||||||
    The meningococcal conjugate vaccine (MenACWY) protects against four types of meningococcal bacteria (types A, C, W, and Y). It is recommended for all kids and teens age 11 and older. Some types of MenACWY are given to younger children (as early as 8 weeks of age) if they have a higher risk of getting meningococcal disease.
    By: dewitian|||||||||
    Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case.
    By: beenoc||||||||| - 2022
DISCLAIMER: All models on adult site are 18 years or older. has a zero-tolerance policy against ILLEGAL pornography. All galleries and links are provided by 3rd parties. We have no control over the content of these pages. We take no responsibility for the content on any website which we link to, please use your own discretion while surfing the porn links.
Contact us | Privacy Policy | 18 USC 2257 | DMCA